Protocol for the LIFEH project: a prospective observational study to explore lifestyle among people living with HIV experiencing weight gain, looking beyond antiretroviral therapy.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
10 Sep 2024
Historique:
medline: 12 9 2024
pubmed: 12 9 2024
entrez: 11 9 2024
Statut: epublish

Résumé

Weight gain, together with the onset of overweight and obesity, is a relevant emerging health issue among people living with HIV (PLWH). A large body of literature recognises this issue as a part of the secondary effects of some antiretroviral therapy (ART), but little is known about the role of lifestyle. In order to assess the role of modifiable aspects of lifestyle in addition to ART on the onset of overweight and obesity, we designed a prospective observational study among PLWH. This is a prospective observational study among PLWH aged 18-65 years attending the Clinic of Infectious Diseases of Spedali Civili, Brescia, Italy, and on ART for at least 24 months. According to the sample size computation, 175 PLWH will be enrolled. PLWH willing to participate in the study are invited to a scheduled clinical visit to collect anthropometric measures, dietary habits and physical activity levels. During the visit, standardised and validated questionnaires are administered regarding emotional distress, food insecurity, use of food supplements, sleep quality, smoking habit and alcohol consumption/risk of addiction. After the interviews, bioimpedance analysis is performed and blood pressure and heart rate are assessed. After 12 months from baseline, each participant will be asked to participate in a further visit, with the same assessments as at baseline. The primary objective of the study is to assess the role of the modifiable factors of lifestyle in the onset of overweight and/or obesity among on-treatment PLWH experiencing weight gain, focusing on diet and physical activity. The study research protocol and informed consent procedures were approved by Ethics Committee of Brescia Province (Italy) on 23 May 2023 (NP5892). Informed consent will be obtained from participants. Results will be submitted for publication in international peer-reviewed journals and summaries will be provided annually to the funders.

Identifiants

pubmed: 39260867
pii: bmjopen-2024-086866
doi: 10.1136/bmjopen-2024-086866
doi:

Substances chimiques

Anti-Retroviral Agents 0

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

e086866

Informations de copyright

© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Auteurs

Barbara Zanini (B)

Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy barbara.zanini@unibs.it.

Martina Salvi (M)

Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
ASST Spedali Civili di Brescia, Brescia, Italy.

Silvia Marconi (S)

Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.

Giorgio Tiecco (G)

Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
ASST Spedali Civili di Brescia, Brescia, Italy.

Giulia Gilberti (G)

Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.

Maurizio Castellano (M)

Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
ASST Spedali Civili di Brescia, Brescia, Italy.

Eugenia Quiros-Roldan (E)

Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.
ASST Spedali Civili di Brescia, Brescia, Italy.

Lifeh Collaboration Group (L)

University of Brescia, Brescia, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH